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ABSTRACT 18 
Second and third generation sequencing methods are crucial for population genetic studies, and 19 
variant detection is a popular approach for exploiting this sequence data. While mini- and 20 
microsatellites are historically useful markers for studying important protozoa such as 21 
Toxoplasma and Plasmodium sp., detecting non-repetitive variants such as those found in 22 
genes, can be fundamental to investigating a pathogens’ biology. These variants, namely single 23 
nucleotide polymorphisms (SNPs) and insertions and deletions (indels), can help elucidate the 24 
genetic basis of an organism’s pathogenicity, identify selective pressures, and resolve 25 
phylogenetic relationships. They also have the added benefit of possessing a comparatively 26 
low mutation rate, which contributes to their stability. However, there are a plethora of variant 27 
analysis tools with nuanced pipelines and conflicting recommendations for best practice, which 28 
can be confounding. This lack of standardisation means that variant analysis requires careful 29 
parameter optimisation, an understanding of its limitations, and the availability of high-quality 30 
data. This review explores the value of variant detection when applied to non-model organisms, 31 
such as clinically important protozoan pathogens. The limitations of current methods are 32 
discussed, including special considerations that require the end-users’ attention to ensure that 33 
the results generated are reproducible, and the biological conclusions drawn are valid. 34 
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1. Introduction 38 
The process of mutation gives rise to genetic variation in non-coding and coding genomic 39 
regions resulting in genetic differences that accumulate over time, slowly culminating in the 40 
molecular divergence of populations. These genetic differences can be exploited to distinguish 41 
divergent populations at the molecular level. Repetitive sequences that occur in coding and 42 
non-coding DNA, known as mini- and microsatellites, have become popular genotyping 43 
markers for use in population diversity studies involving many protozoan pathogens (Al-44 
Qassab et al., 2010; Anderson et al., 2000; Basso et al., 2009; Das et al., 2016). However, it is 45 
the study of variants present in genes that advances our understanding of whether a mutation 46 
has altered a genes’ function and consequently, the organism’s phenotype. Genetic variants 47 
considered pertinent to the study of gene function are single nucleotide polymorphisms (SNPs), 48 
and insertions & deletions (indels). Larger sequence variants are also biologically and 49 
functionally important polymorphisms, and include structural variants (SVs) such as 50 
transversions, copy number variation (CNV), inversions, and duplications. Each of these 51 
polymorphisms can be identified through in-silico variant analysis methods applied to next- 52 
and third generation sequencing (TGS) data, which have superseded Sanger sequencing for 53 
many applications. Ultimately, demand for the development and improvement of in-silico tools 54 
to perform variant analyses stems from the continued advancement and increasing availability 55 
of high-throughput sequencing technologies. 56 
 This review provides an update on the state of the art regarding sequencing technologies 57 
and variant calling pipelines, and their applications in parasitology. These topics are first 58 
discussed from a generalist perspective by highlighting the importance, applications, and 59 
challenges associated with sequencing and variant detection. Next, the discussion focuses on 60 
how these technologies apply to the study of clinically important protozoan pathogens, and 61 
considerations that require attention when studying unique, complex, and peculiar parasite 62 
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genomes. Advances arising from the application of these technologies to several protozoan 63 
pathogens are highlighted, including population genetic studies of Toxoplasma gondii, 64 
Leishmania sp., and Trypanosoma cruzi, and the detection of drug resistance variants in 65 
Plasmodium species. Finally, we provide recommendations on best practice with regards to 66 
variant detection, including its application to non-model organisms, in which case, robust 67 
genomic resources are often unavailable. 68 
 69 
2. Current sequencing technologies and their challenges 70 
2.1. Overview of current technologies 71 
The advancement of first and second generation sequencing (SGS) technologies over the past 72 
20 years has revolutionised genetic research, facilitating several major scientific advancements. 73 
The evolution of next generation sequencing (NGS) technologies has seen the development of 74 
platforms that boast high speed, massive throughput, enormous data generation, and 75 
affordability (Ambardar et al., 2016). Such technology has also been applied in fields of 76 
diagnostics and sequencing of organellar genomes (Flaherty et al., 2018; Jex et al., 2010; 77 
Roeber et al., 2013). However, the ongoing development of new technologies continues, each 78 
offering a range of advantages and limitations that vary between platforms. Consequently, the 79 
choice of sequencing platform must be considered depending on the desired outcome or 80 
specific research question, as well as the nature of the organism under investigation.  81 
 Second generation sequencing technologies first emerged with the commercialisation of 82 
Roche’s 454 pyrosequencing platform in 2005, which accommodates a wide scope of 83 
applications including RNA- and DNA-sequencing, metagenomics, and targeted amplicon 84 
sequencing (Ambardar et al., 2016; Tripathi et al., 2016). Following the release of the Genome 85 
Analyzer platform in 2007 however, commercially available Illumina platforms have become 86 
the standard for high-throughput, massively paralleled sequencing, and are the only platforms 87 
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capable of paired-end sequencing (Ambardar et al., 2016; Quail et al., 2012). This facilitates 88 
the production of high-quality data, leads to higher read coverage, and aids in the discovery of 89 
structural variants and repetitive sequence elements (Ambardar et al., 2016). Other notable 90 
SGS technologies include ABI/Life Technologies’ SOLiD (Sequencing by Oligonucleotide 91 
Ligation and Detection) platform and Life Technologies’ Ion Torrent PGM (Personal Genomic 92 
Machine). The SOLiD platform executes multiple sequencing rounds resulting in an overall 93 
base calling accuracy of >99.85% (Kchouk et al., 2017; Mardis, 2013), whereas Ion Torrent 94 
sequencers produce comparatively longer reads between 35-400 bp (average 200 bp), with 95 
higher throughput and faster run times compared to other SGS platforms (Eid et al., 2009; 96 
Rothberg et al., 2011).  97 
 Alternatively, rather than relying on PCR to enrich DNA template prior to sequencing, 98 
developing TGS technologies target single DNA molecules directly through single molecule 99 
real time (SMRT) sequencing technology (Braslavsky et al., 2003; Eid et al., 2009; Harris et 100 
al., 2008). This results in longer reads being generated, a faster sequencing time, and eliminates 101 
some sequencing biases introduced by PCR amplification (Lu et al., 2016; Schadt et al., 2010). 102 
Pacific Biosciences’ (PacBio; www.pacb.com) commercialisation of SMRT sequencing in 103 
2011 paved the way for this technology, and is currently the most widely used TGS technology 104 
commercially available (Eid et al., 2009). Its advantages include the production of reads 105 
substantially longer than those generated by any SGS technology, averaging up to 30,000 bp, 106 
and comparatively rapid sample preparation (Chin et al., 2016; Liu et al., 2012). In 2014 a new 107 
TGS platform known as the MinION device was released by Oxford Nanopore Technologies 108 
(ONT) (Lu et al., 2016), where its main appeal is portability and affordability, making it 109 
conducive to real-time applications. Furthermore, its ability to generate long reads (generally 110 
>10 kilobases (kb)) lends itself to the detection of structural genomic variants and repeat 111 
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sequences, which is especially relevant for the complex genomes of many Protozoa 112 
(Laehnemann et al., 2016; Lu et al., 2016; Mikheyev and Tin, 2014).   113 
 114 
2.2. Limitations and challenges of sequencing technologies 115 
While the advent of SGS technologies saw unprecedented large and affordable throughput, 116 
these platforms were not without their limitations. The short sequencing reads produced by 117 
SGS platforms for example are not conducive to de novo genome analyses, and can result in 118 
the generation of highly fragmented assemblies, which is particularly problematic for the large 119 
repetitive genomes of eukaryotic pathogens (Ambardar et al., 2016; Korhonen et al., 2016; 120 
Schatz et al., 2010). With the development of TGS technologies however, arguably the greatest 121 
concern is that TGS platforms currently introduce sequencing errors at rates approximately 10-122 
15% higher than SGS platforms (Mardis, 2013; Nagarajan and Pop, 2013). Furthermore, ONT 123 
base calling errors are currently higher than PacBio, with correct base calling rates of 124 
approximately 65-88% (Ashton et al., 2015; Ip et al., 2015; Laver et al., 2015).  125 
 When selecting a specific SGS or TGS technology for a sequencing task, the main trade-126 
off between platforms is data volume versus read length. The economical production of copious 127 
amounts of sequence data using the highly paralleled sequencing chemistries offered by SGS 128 
technologies is available at the expense of read length and PCR bias. This is compared to the 129 
rapid, real-time production of long reads from TGS technologies that improve de novo 130 
assembly quality, where these advantages exist at the expense of higher error rates and lower 131 
throughput. In an attempt to overcome these challenges, it has become common practice to 132 
perform hybrid de novo assemblies, whereby reads generated by SGS and TGS platforms are 133 
combined in the same assembly, where the lower error rates introduced by SGS platforms 134 
offset the high error rates of TGS platforms, while the longer TGS reads help to close genomes. 135 
This approach in particular has gained momentum for various protozoans, where previously 136 
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published genomes suffer from the disadvantages of using data generated from either 137 
sequencing technology alone (Batra et al., 2019; Bruske et al., 2018; Diaz-Viraque et al., 2019; 138 
Gonzalez-de la Fuente et al., 2018; Gonzalez-de la Fuente et al., 2017).  139 
 140 
2.3. Sequencing considerations for clinically significant Protozoa 141 
It is well accepted that the more complex and repetitive the genome, the lower the quality of 142 
the assembled genome sequence. This is especially true for pathogenic Protozoa, where the 143 
unique nature of their genomes poses many challenges pertinent to sequencing and subsequent 144 
analysis of generated reads. For example, short reads generated by SGS platforms make it 145 
nearly impossible to assemble repetitive regions that are characteristic of many parasite 146 
genomes. However, long reads generated using newer TGS platforms provide an attractive 147 
alternative for addressing such challenges. Subsequently, many studies have emerged recently 148 
that take advantage of new TGS technologies, to improve the genome quality, completeness, 149 
and annotation of clinically significant parasites (Berna et al., 2018; Chien et al., 2016; Otto et 150 
al., 2018; Vembar et al., 2016). However, the advantages and appeal of NGS platforms are 151 
impeded by their costs, sample preparation, and availability in remote hospitals and field 152 
settings. This is a concern in developing countries where many pathogenic Protozoa are 153 
endemic. New platforms such as Nanopore’s MinION sequencer aim to address this, where 154 
laborious sample preparation and skilled technicians are not required  (Lu et al., 2016). 155 
 Limitations in the genome assemblies of protozoans hinder precise comparative 156 
genomics and transcriptomics, gene expression studies, and gene content analysis, which are 157 
crucial for understanding the nature and progression of these diseases (Berna et al., 2018; Chien 158 
et al., 2016). Furthermore, gaps or absent regions within genome assemblies due to the 159 
limitations of available technologies, impede the detection and analysis of genetic variation 160 
such as indels, SVs, CNVs, chromosomal rearrangements, and hypervariable multi-gene 161 
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families (Kwiatkowski, 2015). Due to the inability of many NGS technologies to address the 162 
peculiarities of parasite genomes such as P. falciparum, sequencing studies tend to focus on 163 
small variants such as SNPs and indels, and neglect or underestimate the presence and 164 
importance of large structural variants in highly repetitive and hypervariable regions. 165 
 While Plasmodium falciparum has a comparatively small eukaryotic genome at ~23 Mb 166 
in length, it has a high repeat content of 51.8%, and is AT-rich with an AT content of 80.6% 167 
(Gardner et al., 2002; Girgis, 2015). Furthermore, the genomes of many Plasmodium species 168 
have polymorphic, repetitive subtelomeric regions encoding multi-gene virulence families 169 
(Chien et al., 2016; Su et al., 1995; Vembar et al., 2016). As a result, NGS capabilities have 170 
fallen short when employed to accurately sequence P. falciparum and other Plasmodium 171 
species (Oyola et al., 2014; Oyola et al., 2012; Quail et al., 2012), and the use of available 172 
genome sequences as references for clinical isolates has been called into question when 173 
studying genetic diversity (Kwiatkowski, 2015). Routine use of PCR-based whole genome 174 
amplification (WGA) has previously contributed to short read sequencing of clinical and 175 
laboratory-derived P. falciparum strains (Ariey et al., 2014; Kamau et al., 2015; Manske et al., 176 
2012), where multiplexed Illumina libraries can also be generated using very low genomic 177 
DNA quantities for this species (Oyola et al., 2014). This is especially relevant in the context 178 
of processing clinical samples either in the field, or other resource limited settings. However, 179 
it has been suggested that PCR-induced bias or sequencing errors can result in overestimating 180 
SNP numbers (Oyola et al., 2014; Vembar et al., 2016).  181 
 Newer technologies such as PacBio’s SMRT sequencing have subsequently been 182 
exploited to overcome these limitations. Vembar et al. (2016) performed amplification-free 183 
long-read sequencing of P. falciparum genomic DNA, where the produced reads were used to 184 
generate a complete telomere-to-telomere de novo assembly. This method also resolved AT-185 
rich centromeres and repetitive subtelomeric regions, and identified large insertions, 186 
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duplications, and expansions, where the improved genome was in turn used to estimate P. 187 
falciparum genetic diversity.  188 
 Comparatively, while the publication of genomes from Leishmania. major (Ivens et al., 189 
2005), Trypanosoma brucei (Berriman et al., 2005), and T. cruzi (El-Sayed et al., 2005) in 2005 190 
represented important milestones in trypanosomatid research, each of these genomes were at 191 
varying degrees of completion, and were plagued by fragmentation. The sequencing of 192 
additional T. cruzi strains was subsequently performed using newer NGS technologies such as 193 
Roche 454 and Illumina, however issues of fragmentation and the collapsing of repetitive 194 
sequences still persisted (Franzen et al., 2012; Grisard et al., 2014). Another known 195 
characteristic of T. cruzi and other trypanosome genomes is that gene content is greatly 196 
expanded, mainly as a result of multi-gene families (Acosta-Serrano et al., 2001; Buscaglia et 197 
al., 2006; Frasch, 2000; Pita et al., 2019). The failure of NGS technologies to account for these 198 
novel genomic features therefore resulted in miscalculation of protein-coding genes, 199 
pseudogenes, copy number estimates, and tandem repeats in these species (Arner et al., 2007; 200 
El-Sayed et al., 2005). The advent of TGS technologies has subsequently allowed accurate 201 
estimations of gene copy number, tandem and dispersed repetitive sequences, and the correct 202 
assembly of homologous chromosomes to retrieve haplotypes (Berna et al., 2018; Callejas-203 
Hernandez et al., 2018; Diaz-Viraque et al., 2019; Jayaraman et al., 2019). 204 
 Quail et al. (2012) compared the performance of three popular NGS platforms with 205 
respect to coverage, GC distribution, variant calling, and accuracy. This study reported several 206 
differences between the quality of the data produced by each platform, though the Ion Torrent, 207 
PacBio, and MiSeq platforms each displayed almost perfect coverage performance for GC-208 
rich, AT-rich, and neutral genomes. However, approximately 30% of the AT-rich Plasmodium 209 
falciparum genome had no coverage on Ion Torrent’s PGM platform. Additionally, while more 210 
true variants could be called from data produced by the PGM platform compared to that of the 211 
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MiSeq, the trade-off was a higher false positive rate. Similarly, while variants could also be 212 
identified using PacBio data, sequencing depth was lacking.  213 
 Ultimately, second and TGS data analysis is complex, requires powerful computational 214 
resources, usually involves multi-step workflows, and requires numerous algorithms and 215 
software for processing depending on the research question (Pabinger et al., 2014). 216 
Furthermore, with the rapid evolution of newer sequencing technologies, selecting the most 217 
suitable technology for a specific application, such as variant detection, is becoming 218 
increasingly difficult, especially in the context of unique protozoan genomes. 219 
 220 
3. Applications of sequencing technologies: variant analysis workflows 221 
An important use of SGS and TGS data is the identification of sequence variants within and 222 
between samples. After selecting the most suitable sequencing strategy for an intended 223 
application, the choice of analysis tools employed, the associated parameters, and the nature of 224 
the organism under investigation, can have a drastic impact on the success of a variant analysis 225 
workflow. A variant analysis workflow (Figure 1) first involves the generation of SGS and/or 226 
TGS data. Read quality control ensues and includes processes such as read trimming to remove 227 
adapter sequence and low quality bases at the ends of reads, and filtering to remove short and 228 
poor quality reads. Groomed reads are then typically mapped to a reference genome or 229 
transcriptome, to allow for subsequent variant calling and annotation.  230 
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 231 
Figure 1. Summary of a typical variant detection workflow for NGS and TGS data. 
Following selection of an appropriate platform and generation of sequencing data, analysis begins with in-silico data pre-processing. Initially, 
sequenced reads are quality controlled using an appropriate tool, and subsequently visualised using an interface such as FastQC. The groomed 
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reads are then aligned to a reference genome using a read mapper such as BWA or Bowtie2, where the user needs to consider alignment parameters, 
and the quality of the reference. Additional processing steps can also be executed, such as those recommended by the Genome Analysis Toolkit 
(GATK), to generate an analysis read Binary Alignment Map (BAM) file. Variants such as single nucleotide polymorphisms (SNPs), insertions 
and deletions (indels), structural variants (SVs), and copy number variants (CNVs) are detected based on sequence differences between the 
reference and sample reads under investigation, with respect to read mapping, quality, and coverage. The putative variants in a Variant Call File 
(VCF) are subsequently filtered and visualised to produce a high-quality callset. Next, a set of high-confidence variants identified in-silico, is 
subject to laboratory validation, which can be problematic depending on the type of variant under investigation. This can involve designing primers 
flanking the predicted variant, and subsequent PCR and sequencing analysis, where returned sequencing data can be evaluated for the presence of 
the putative variant. Lastly, in-silico variants are annotated to elucidate their biological relevance, phylogenetic relationships, population genetics, 




3.1. Read quality control and mapping 233 
Implementation of appropriate quality control measures for raw SGS and TGS reads prior to 234 
data analysis is essential to remove reads containing obvious base calling errors, poor quality 235 
sequence, small indels, and adaptor sequences (Dai et al., 2010). There are several tools 236 
available for performing each of these tasks, many of which perform overlapping functions. 237 
These include the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), which is a 238 
command-line tool designed to pre-process NGS reads, with the capacity to trim and quality 239 
filter reads, in addition to converting file formats and providing summary statistics. 240 
Additionally, Trim Galore (www.bioinformatics.babraham.ac.uk/projects/trim_galore/) offers 241 
automation in a Perl wrapper script to trim adapter sequences, filter base quality scores, and 242 
remove short reads. Subsequently, tools such as FastQC 243 
(www.bioinformatics.babraham.ac.uk/projects/fastqc/) can assess the quality of sequence data 244 
in an easy to use interface, and report the results in summary graphs and tables. Read grooming 245 
results in retention of only high-quality reads which facilitate an accurate alignment, mitigating 246 
the risk of calling false variants during downstream analyses (Nielsen et al., 2011).  247 
 Accurate alignment of groomed reads from a RNA-seq or DNA-seq experiment is critical 248 
for variant calling accuracy, as correct mapping will avoid the erroneous interpretation of 249 
misaligned reads as true variants (Piskol et al., 2013). Hence, when selecting one of the several 250 
alignment tools available (Table 1), consideration of its tolerance for imperfect matches is 251 
critical (Bao et al., 2014). For example, Bowtie2 offers accurate read alignment for reads of 252 
varying lengths, as generated from a range of sequencing technologies (Langmead and 253 
Salzberg, 2012). This tool has evolved with advancing sequencing chemistries, 254 
accommodating increasing throughputs and read lengths. The algorithm also achieves sensitive 255 
gapped-read alignments, where gaps can be an error source associated with new single-256 
molecule sequencing technologies. By comparison, the Burrows-Wheeler Aligner’s (BWA) 257 
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‘BWA-MEM alignment algorithm has been reported to perform well for longer reads, and be 258 
more accurate than Bowtie2 (Li, 2013), whereas Bowtie2 is faster and more accurate when 259 
handling indels (Langmead and Salzberg, 2012). Furthermore, tools including TopHat2 (Kim 260 
et al., 2013), STAR (Spliced Transcripts Alignment to a Reference) (Dobin et al., 2013), and 261 
RUM (RNA-seq Unified Mapper) (Grant et al., 2011) are specifically designed for aligning 262 
RNA-seq reads, whilst addressing associated challenges such as alternative splicing, indels, 263 
gene fusions, and introns. 264 
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Table 1. List of available sequence alignment tools for NGS analysis. 265 
Sequence alignment tool Features Reference 
TopHat and TopHat2 
Spliced aligner for RNA-seq data which can also identify novel splice sites, 
and produce accurate alignments for highly repetitive genomes in the presence 
of indels and gene fusions 
(Kim et al., 2013; Trapnell 
et al., 2009) 
Bowtie and Bowtie2 
Offers accurate alignments for reads of varying lengths produced from a range 
of sequencing technologies. Bowtie2 achieves sensitive gapped-read 
alignments, where gaps can be an error source associated with single-molecule 
sequencing technologies 
(Langmead et al., 2009) 
Burrows-Wheeler Aligner 
(BWA) 
Efficient and accurate alignment of short and long sequencing reads against 
large reference sequences. Allows for mismatches and gaps originating from 
sequencing when performing alignments 
(Li and Durbin, 2009, 
2010) 
SOAP and SOAP2 
An ultrafast and memory efficient short read aligner that supports multiple 
input and output file formats. SOAP and SOAP2 are compatible with both 
(Li et al., 2008; Li et al., 
2009b) 
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single- and paired-end reads and are capable of gapped and ungapped 
alignments 
Spliced Transcripts Alignment 
to a Reference (STAR) 
Flexible, ultrafast RNA-seq alignment tool compatible with a range of second 
and third generation sequencing platforms. Able to align high-throughput 
short and long RNA-seq reads 
(Dobin et al., 2013) 
MapSplice 
Splice detection algorithm that can align both short and long RNA-seq reads. 
Can be applied to data from model organisms, as well as those with limited 
transcript annotations 
(Wang et al., 2010b) 
RNA-seq Unified Mapper 
(RUM) 
RNA-seq alignment algorithm that addresses the main challenges associated 
with RNA alignment such as alternative splicing, indels, base substitutions, 
base calling errors, and introns 
(Grant et al., 2011) 
  266 
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 A common optimisation strategy for not only selecting a suitable alignment tool, but also 267 
an appropriate set of parameters and their thresholds, is to execute multiple rounds of read 268 
mapping within and between aligners (Calarco et al., 2018). The suitability of both the aligner 269 
and its specific parameters can subsequently be assessed using the read statistics produced by 270 
tools such as Bowtie2 and TopHat2. For example, the overall percentage of reads mapped to 271 
the reference can be compared, in addition to the number of concordant or discordant pairs 272 
mapped, in the case of paired-end reads. Through this approach, the user’s own data is being 273 
employed to optimise and tailor the read mapping process, as opposed to using the pre-defined 274 
default thresholds of the respective tools, which are usually trained on and designed for data 275 
generated from model organisms such as humans. 276 
 Additional processing of sequencing data and aligned reads is also routinely required by 277 
downstream tools. Manipulation of such data in file formats such as SAM, BAM, and VCF can 278 
involve marking duplicate reads, performing realignment around potential indel sites, sorting 279 
and indexing alignment files, collecting metrics, and converting files. Picard tools (Broad 280 
Institute, 2019) and SAMtools (Li et al., 2009a) are extremely valuable toolkits that can 281 
perform such commands amongst a plethora of others, and are incorporated into many “gold 282 
standard” or “best practice” workflows, such as the Genome Analysis Toolkit (GATK) 283 
(McKenna et al., 2010) and VarScan (Koboldt et al., 2009). For example, identifying and 284 
removing duplicate sequenced reads is an important processing step, where such reads can 285 
occur as a result of library preparation during PCR enrichment. If a PCR duplicate is sequenced 286 
multiple times and contains an amplification-derived error, this can introduce bias in 287 
downstream variant analysis, where a variant caller may incorrectly identify this error as a true 288 
variant, or miscalculate the frequency in which the allele is represented (Ebbert et al., 2016). 289 
Adding read group information using these toolkits is also extremely useful, and even required 290 
by many variant callers such as VarScan, when attempting to identify variants across multiple 291 
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samples or populations. This is especially relevant for Protozoa, where sequencing is frequently 292 
performed on multiple isolates or passages, and on clinical samples that may be pooled from 293 
multiple patients. The toolkits discussed are user-friendly and are accompanied by extensive 294 
documentation and usage recommendations, making them ideal for streamlining analysis 295 
pipelines, and also for inexperienced users. 296 
 297 
3.2. Variant calling and visualisation 298 
Following alignment, the mapped reads are then subject to a variant detection workflow for 299 
identification of SNPs and indels (Pabinger et al., 2014). As some variants may result from 300 
sequencing or mapping errors, a balance between sensitivity to minimise false negatives, and 301 
specificity to minimise false positives, is essential. Consequently, the variant calling step is 302 
generally designed to maximise sensitivity, while downstream filtering offers specificity. 303 
Manual visualisation of at least a subset of alignments can be a crucial step in a variant 304 
identification workflow, as this can aid in interpreting results and determining the confidence 305 
of variant calls. This is also useful as an additional validation step prior to confirmation of 306 
certain variants by downstream PCR and Sanger sequencing.  307 
 Several visualisation tools are available, which possess useful capabilities, including the 308 
visualisation of mapped reads in the context of the reference genome, displaying read mapping 309 
quality, and highlighting variants. Visualising read alignment files in the context of a reference 310 
can also assist in assessing the suitability of software and pipelines employed. This can include 311 
visualising the adequacy of read coverage across specific loci, and for de novo assemblies, can 312 
be used to aid in the selection and optimisation of assembly and alignment tools and their 313 
parameters. Additionally, manually visualising alignments can be used to assess the potential 314 
existence of mixed infections or multiple populations present in a sample, based on the 315 
proportion of reads containing SNPs and indels. Popular user-friendly tools include the 316 
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Integrative Genomics Viewer (IGV) (Thorvaldsdottir et al., 2013), Artemis (Carver et al., 317 
2012), and Savant (Fiume et al., 2010). 318 
 319 
3.3. Annotating variants and identifying functionally significant mutations  320 
The variants are then annotated to elucidate their functional and biological relevance (Pabinger 321 
et al., 2014). Annotation of variants (i.e., assigning relevant biological information to these 322 
sites) can include identifying genes effected by the variant, determining whether it falls in a 323 
non-coding or coding region, introduces (or removes) a stop codon, or whether it is a silent, 324 
missense or nonsense mutation (McCarthy et al., 2014). Annotation tools typically assign 325 
general attributes to each putative variant, which helps investigators assess their potential 326 
impact on the organism. For example, tools such as ANNOVAR (Wang et al., 2010a) and 327 
SnpEff (Cingolani et al., 2012) can provide information on the impact a sequence variant may 328 
have on a genes’ function, compare results to existing variant databases, predict the coding 329 
effects of SNPs and indels, and identify mutation effects such as non-synonymous and 330 
synonymous substitutions, frame shifts, stop codon insertions, and mutated start codons. 331 
 If a mutation is identified within a protein-coding gene, its functional impact can be 332 
predicted using orthology, where similar sequences of known function might be present in 333 
databases such as UniProt (The UniProt Consortium, 2017), and identified by BLAST analysis 334 
(Conesa et al., 2016). InterPro is a valuable resource that provides functional analysis of protein 335 
sequences by integrating several different databases (Finn et al., 2017). The collective database 336 
assigns protein sequences to families, predicts domains and other important motifs, provides 337 
residue-level annotation, and intrinsic protein disorder predictions. A limitation of some 338 
annotation tools however, is their inability to support the submission of a large unified set of 339 
variants, rendering their use for only the manual analysis of select variants. 340 
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 Alternatively, identifying sequence variants within non-coding genomic regions has 341 
gained momentum over the last decade, with a focus on how they affect regulatory elements, 342 
such as promoters, enhancers, and transcription factor binding sites (TFBSs), and consequently 343 
gene expression and disease (Narlikar and Ovcharenko, 2009). Tools such as the 344 
VariantAnnotation Bioconductor package (Obenchain et al., 2014) available in R (www.R-345 
project.org), contain useful commands to allocate SNPs to either coding, intron, intergenic, 3 346 
untranslated, 5 untranslated, promoter, or splice site regions within a gene. Tools such as these 347 
generally require a Generic Feature Format (GFF) file to be available for the organism under 348 
investigation, that contains gene sequence annotations. The region-based annotation function 349 
component of the ANNOVAR package is also able to identify variants that disrupt enhancers, 350 
repressors, and promoters, and those that are located within TFBSs. However, such tools 351 
generally only accommodate well-studied model organisms, for which required datasets are 352 
available.  353 
 The final step in a variant calling workflow involves prioritising the variants down to a 354 
reportable or experimentally confirmable set that can be validated in the laboratory by PCR 355 
and Sanger sequencing if deemed necessary (Pabinger et al., 2014). One limitation with popular 356 
variant calling pipelines (Table 2), is the absence of well-defined filtering strategies and 357 
thresholds to apply to individual callsets, where there is currently a scarcity of any consensus 358 
or direction in the literature. Nonetheless, Table 3 summarises popular techniques to select for 359 
high-quality, functionally significant variants. 360 
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Table 2. Features and considerations of popular variant calling software. 361 
Variant Caller Features  Considerations  Reference 
GATKI 
Superior processing steps including realignment and base 
quality score recalibration 
Requires a database of known variant sites to 
perform base recalibration, which is not 
suitable for non-model organisms or those 




Contains tools for sorting, indexing and formatting input 
reads, to subsequently subject to variant detection using 
BCFtools 
Support for and extent of filtering options 
available for variant calls is limited 
(Li et al., 
2009a) 
Geneious 
Provides an all-inclusive interface for analysing NGS data, 
including read pre-processing, alignment, variant calling, 
visualisation, and annotation 




Atlas2 Separately calls and identifies SNPsII and indelsIII 
Only supports single sample variant calling 
and is specifically designed for exome 
sequencing analysis 
(Challis et al., 
2012) 
VarScan 
Separately calls SNPs and indels with a short run-time and 
compatibility with several short aligners 
Using default parameters can result in a high 
false-positive variant discovery rate, and 
therefore requires optimisation by the user 




Calls SNPs and indels between a haploid reference genome 
and NGS reads. The results can be used to generate a core 
SNP alignment, and phylogenomic trees 
Originally designed for short reads generated 
from bacterial genomes, and uses an internal 




An automated variant calling pipeline to detect SNPs and 
indels, by integrating eight variant calling tools 
Tool-specific filtration steps are not taken into 
consideration, where instead default options 




Models multi-allelic loci in sets of individuals with non-
uniform copy number 
The pipeline is based on a minimal pre-
processing approach, and does not support 




Detects variants with a greater accuracy than conventional 
methods, using deep neural networks 
Run time is considerably slower compared to 
other gold standard variant callers 
(Poplin et al., 
2018) 
 362 
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Table 3. List of recommended filtering strategies to obtain high confidence variant 371 
callsets, following in-silico detection. 372 
 373 
Filtering strategy Purpose Reference 
Sequence 
coverage/depth 
To ensure the existence of a variant can be 
substantiated across multiple reads, during the 
visualisation step 
(Reumers et al., 2012) 
Reported base quality 
Filter based on quality scores assigned to each base 
during sequencing, that represent the confidence of 
each base called 
(Park et al., 2014) 
Strand bias 
Filter based on a reported metric that uses the 
Fisher’s Exact Test to detect strand bias in the reads 
(Park et al., 2014) 
Variants within 
homopolymer runs 
Error source associated with DNA sequencing (Reumers et al., 2012) 
Annotation 
Annotate variants to select for those located within 
functionally significant genomic regions 
(Pabinger et al., 2014) 
Consensus variants 
Final callset should be comprised of consensus 
variants called by multiple variant calling pipelines 
(Bao et al., 2014; 
O'Rawe et al., 2013; 
Pabinger et al., 2014) 
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Next Generation Sequencing data analysis can be daunting due to the wealth of tools 374 
available, the optimisation and tailoring of pipelines required, and the need to be familiar with 375 
implementing algorithms and scripts via command-line. As a result, many easy to use and 376 
publicly accessible interfaces and software platforms have been developed to help streamline 377 
and automate NGS analysis, including variant detection pipelines with recommendations on 378 
best practices. For example, Geneious (www.geneious.com) is a sequence analysis software 379 
platform that provides a user-friendly interface of bioinformatics tools and workflows. 380 
Importing raw sequencing data in a variety of formats is a simple ‘drag and drop’ process, 381 
where such data can subsequently be pre-processed with integrated tools for trimming, 382 
filtering, adaptor removal, and normalisation. The Geneious package accommodates for the 383 
analysis of reads of any length generated by Illumina, PacBio, Roche 454, Nanopore, and Ion 384 
Torrent platforms, including de novo assembly, read alignment to a reference, variant detection, 385 
genome visualisation and annotation, and gene expression. Furthermore, the platform offers a 386 
range of tutorials and application support for researchers planning on implementing various 387 
types of analysis pipelines.  388 
The Broad Institute’s GATK offers a range of tools for variant identification and 389 
genotyping using high-throughput sequencing data (McKenna et al., 2010). GATK offers an 390 
industry standard, best practice pipeline for germline and somatic short variant and structural 391 
variant discovery using DNA and RNA-seq data (https://software.broadinstitute.org/gatk/best-392 
practices). While originally designed for the processing of whole genomes or exomes produced 393 
by Illumina platforms, this toolkit can be adapted to accommodate for other sequencing 394 
technologies and any organism, not just for studying human genetics. It can also perform 395 
additional tasks pertinent to pre-processing of high-throughput sequencing data, and offers 396 
extensive tutorials and support.  397 
 398 
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4. The importance of variant detection in molecular research 399 
In biological and medical fields, the association between genotype and phenotype is an 400 
essential line of research (Consortium et al., 2010). The advent of NGS technologies has 401 
delivered large volumes of DNA sequence data paving the way for an improved understanding 402 
of disease processes, gene expression, and population genetics (Nielsen et al., 2011). The 403 
increasing availability of SGS and TGS technologies has led to a shift from simply performing 404 
genome sequencing for the sake of generating new genomes, towards analysing sequence data 405 
to discover novel sequence variants between genomes. 406 
Detection of SNPs and indels offers several advantages over the use of alternative 407 
markers such as mini- and microsatellites for research applications in population diversity and 408 
genotyping. By nature, SNPs are extremely stable, exhibit low mutation rates, and are present 409 
throughout the entire genome (Picoult-Newberg et al., 1999). They are the most common 410 
genetic marker (Sachidanandam et al., 2001; Sherry et al., 1999), and are consequently very 411 
informative, providing a genome-wide representation of natural variation in populations (Vera 412 
et al., 2013). Additionally, despite microsatellites commonly exhibiting greater allelic diversity 413 
per locus, SNPs reportedly exhibit strong segregation among populations (Karlsson et al., 414 
2011; Vera et al., 2013), making them an ideal target for identifying loci that may be subject 415 
to neutral variation or undergoing selection (Helyar et al., 2011).  416 
 417 
4.1. Detecting evolutionary selection 418 
There are a myriad of methods available to support the downstream analysis of confirmed 419 
sequence variants that complement the burgeoning field of SNP detection. Generally, these 420 
tools attempt to predict the type of selection that may be acting on a protein-coding gene, and 421 
to what effect, which provides information on their biological significance (Jeffares et al., 422 
2015). A mutation that surfaces in a population can be classified as advantageous, deleterious, 423 
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or neutral (Thiltgen et al., 2017), and elucidating the mechanisms that either result in the 424 
maintenance or loss of these sequence polymorphisms is an important question in population 425 
genetics (Escalante et al., 1998). Estimating the ratio of non-synonymous to synonymous 426 
mutations (dN/dS) can reveal whether positive diversifying, negative purifying, or neutral 427 
selection is acting on a gene (Jeffares et al., 2015). There are several tools widely available for 428 
determining rates of mutation and calculating these statistics. 429 
  The PAML software package uses maximum likelihood (ML) for phylogenetic 430 
analyses of DNA and protein sequences (Yang, 1997, 2007). Various PAML programs can 431 
estimate non-synonymous and synonymous substitution rates in protein-coding sequences 432 
from several species within a population and can detect positive Darwinian selection. DnaSP, 433 
offers numerous tools for the analysis and visualisation of sequence variation both within and 434 
between populations (Rozas et al., 2017). In addition to the commonly exploited loci selection 435 
tests centred around synonymous and non-synonymous substitution rates, DnaSP also includes 436 
tests that estimate linkage disequilibrium, identify recombination, and test for neutrality (i.e., 437 
Tajima’s D (Tajima, 1989) and Fu and Li’s D and F statistic (Fu and Li, 1993)). 438 
PopGenome exploits the full range of capabilities of the R statistical and graphical 439 
environment for population genetics research (Pfeifer et al., 2014). This R package reads DNA 440 
alignments and SNP data in a range of formats (FASTA, MEGA, PHYLIP, and VCF to name 441 
a few), as well as annotation files in GFF (general feature file) format, and links this data to 442 
functionally significant annotations. A key advantage of this software is its support for 443 
analysing genome-scale data, and its ability to produce an array of population genetics statistics 444 
such as linkage disequilibrium, neutrality, and recombination. In addition to these commonly 445 
used statistics, PopGenome offers tests of non-neutral evolution, including the McDonald-446 
Kreitmann test (McDonald and Kreitman, 1991), and calculates a range of fixation indices (i.e., 447 
FST).  448 
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Goodswen et al. (2018) implemented a pipeline optimised for eukaryotic pathogens 449 
that predicts positive selection sites through comparison of synonymous and non-synonymous 450 
mutation rates within protein coding genes. When tested on T. gondii, the pipeline provided a 451 
set of proteins representing potential vaccine candidates, as they were predicted to contain 452 
residues exposed to the immune system that are under positive selection. As part of this 453 
workflow, specific proteins were predicted to be naturally exposed to the immune system 454 
following submission of a set of protein or nucleotide sequences to Vacceed (Goodswen et al., 455 
2014), which is an automated, in-silico pipeline based on reverse vaccinology, that assigns 456 
protein candidates a score between one and zero, where one represents the highest confidence 457 
that a given protein is a suitable vaccine candidate. This pipeline incorporates various tools to 458 
identify secreted and/or membrane-associated proteins, based on predicted subcellular 459 
location, transmembrane topology, signal peptides, and peptide binding to MHC class I and II 460 
molecules. Specifically, Goodswen et al. (2018) identified surface antigens, and dense granule, 461 
microneme, and rhoptry proteins as potential vaccine candidates, as well as two rhoptry 462 
proteins (ROP5 and ROP18), that are known determinants of T. gondii virulence (Lei et al., 463 
2014; Ma et al., 2017). Similarly, the high rate of polymorphisms detected in genes encoding 464 
Plasmodium sp. surface proteins, led to the hypothesis that these proteins were experiencing 465 
positive selection as a consequence of the pressure exerted by the host’s immune system 466 
(Hughes and Hughes, 1995). The high rate of non-synonymous compared to synonymous 467 
mutations in these genes was indicative of diversifying Darwinian selection. Understanding the 468 
selective processes experienced by specific genes can be invaluable for understanding a 469 
protein’s function, processes of adaptation and gene-level natural selection, gene conservation, 470 
and the evolutionary dynamics of genes (Thiltgen et al., 2017). However, the foundation of 471 
these analyses is the accurate detection of SNPs and indels. 472 
 473 
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4.2. Population structure and genetics 474 
Variants detected in-silico can subsequently be exploited to discern a populations’ genetic 475 
structure, where genome-wide SNP studies have the potential to provide a framework for 476 
understanding a species’ population genetics. Principle component analysis (PCA) is routinely 477 
used to analyse SNP data to reveal geographical segregation and genetic diversity within and 478 
between populations (Abraham and Inouye, 2014; Aydemir et al., 2018; Iantorno et al., 2017; 479 
Su et al., 2012). The construction of neighbour-joining (NJ) trees is another popular method 480 
for investigating a populations’ genetic structure (Saitou and Nei, 1987). This can be performed 481 
using various tools such as the ‘nj’ function in R’s ‘ape’ package (https://cran.r-482 
project.org/web/packages/ape/). 483 
Revealing the population-level genetic structure of a species is crucial for 484 
understanding the distribution of its phenotypic features, epidemiology, and molecular 485 
evolution. For protozoan parasites, this might include drug susceptibility patterns or virulence 486 
markers that exist between geographically dispersed populations. For example, examining 487 
genetic differences between T. gondii strains globally led to the discovery of four clonal 488 
lineages responsible for most human infections in the Northern hemisphere (Khan et al., 489 
2011a). The observation that little to no sequence variation exists in chromosome Ia between 490 
T. gondii lineages, also resulted in this entire chromosome being deemed relatively 491 
homogenous between the predominate lineages on different continents (Khan et al., 2006; 492 
Khan et al., 2011b). This led to the conclusion that chromosome Ia experienced a genetic sweep 493 
approximately 10,000 years ago, where the genetic variants on chromosome Ia afforded a 494 
significant Darwinian advantage resulting in their rapid geographical spread (Boyle et al., 495 
2006; Khan et al., 2011b).  496 
 497 
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5. Limitations and challenges of variant analysis 498 
5.1. Considerations within and between variant callers 499 
As the process of SNP and indel detection is based on relatively new technologies, they are not 500 
without their limitations. Furthermore, the large number of variant analysis tools available 501 
means that the challenge of standardisation and accuracy persists (Hanlee, 2012). It would be 502 
erroneous to presume all variant calling tools employ similar approaches to variant detection, 503 
and indeed, some tools possess markedly different sensitivities and specificities (O'Rawe et al., 504 
2013). These differences result from inconsistencies in data collection, read alignment 505 
methods, the alignment parameters selected, post-alignment processing and variant analysis 506 
algorithms. While relatively accurate alignment tools are available for mapping reads to 507 
reference sequences, difficulties still exist in determining whether a variant is real or the result 508 
of error (Hanlee, 2012). Unfortunately, variant calling remains highly variable depending on 509 
the tools and methods used, highlighting the need for improved standardisation.  510 
 Several studies have evaluated and compared variant calling pipelines with respect to 511 
data type, computational considerations, choice of tools, and interpretation of the results 512 
(Altmann et al., 2012; Oliver et al., 2015; Vyas et al., 2016; Xu, 2018). O'Rawe et al. (2013) 513 
analysed raw sequence data with five available variant calling pipelines, under near-default 514 
software parameters and identified a significant number of discrepancies between the tools, 515 
including the omission of true functional variants by some of them. It was therefore 516 
recommended that the variants called by multiple pipelines be considered for downstream 517 
analysis to decrease the possibility of false positives and negatives (Bao et al., 2014; Pabinger 518 
et al., 2014). Ideally, several aligners and variant callers should be employed in a consensus 519 
approach to identify variants of high confidence (Bao et al., 2014; O'Rawe et al., 2013; 520 
Pabinger et al., 2014). Importantly, the calling of variants on multiple replicate samples should 521 
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be incorporated into a workflow to mitigate the influence of random sequencing errors on false 522 
















Figure 2. Example of false-positive and true variants identified by a variant analysis and 
visualised in IGV. 
As displayed in IGV (Thorvaldsdottir et al., 2013), the reference sequence is shown along the 
bottom of each panel and the horizontal grey bars represent the individual Illumina reads that 
successfully aligned to the reference sequence. Vertical dashed lines highlight the location of 
a putative variant that was selected for viewing. The bases in each read that differ to the 
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reference are also shown on the read, and a purple I reflects the presence of an inserted base. 
Panel (a) shows false-positive variant calls due to the incorrect alignment of reads to the 
reference sequence likely due to a large insertion in the reference sequence. Panel (b) shows 
some reads that have been misaligned due to the presence of a repetitive region in the reference 
sequence, resulting in the calling a false positive variant (a “G” base). Panel (c) shows a set of 
variants identified that were confirmed and validated by PCR amplification followed by Sanger 
sequencing. The consistent mapping of reads to this region and the fact that the variants occur 
towards the middle of the reads (as opposed to the ends) and are present in all reads demonstrate 
the appearance of true variants in an alignment. Ultimately, this figure highlights the 
importance of an accurate alignment for calling variants. 
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5.2. Sources of false positive variants 525 
Correct alignment is essential for accurate variant calling. However, as is the case for many 526 
eukaryotic organisms, alignment accuracy is sometimes hampered by the inability of some 527 
algorithms to handle differential RNA splicing (Piskol et al., 2013). While some aligners can 528 
satisfactorily predict alternatively spliced RNAs from RNA-seq data, they still generate an 529 
objectionably high error rate. The use of paired-end sequencing can facilitate the accurate 530 
detection of RNA splice variants, and their use is strongly recommended for whole-exome 531 
sequencing (Pabinger et al., 2014). In addition to splice variants, short indels and repetitive 532 
sequences can be problematic for alignment algorithms, and accurate alignment is often 533 
sacrificed for speed (Bao et al., 2014; Piskol et al., 2013). This can result in erroneous 534 
alignments that can give rise to false variant calls. Short erroneous indels in sequencing reads 535 
can make it difficult for tools to achieve correct alignment and these represent a major source 536 
of false positive errors. Variant calling can be improved by performing a realignment step that 537 
focuses on areas with potential indels, which is a step recommended in the GATK’s Best 538 
Practices Workflow (https://software.broadinstitute.org/gatk/best-practices). This step aids in 539 
producing clean reads with a consensus indel for subsequent variant identification approaches, 540 
for specific regions where misalignments resulting from indels is a possibility. Consequently, 541 
manual examination of variant calls is recommended wherever practical to ensure the selected 542 
alignment algorithm is performing correctly (Figure 2).  543 
 As SGS and TGS data are prone to errors that can lead to false positive variant calls, the 544 
tools, filters and parameters employed are crucial to mitigate this. Various studies have 545 
investigated the cause of false positive variants and the most effective strategies to improve the 546 
accuracy of variant calls (Park et al., 2014; Ribeiro et al., 2015). These studies have found that 547 
variant calling accuracy is dependent on several factors including the quality of the reference, 548 
the selection of alignment algorithm and variant calling software, the alignment stringency, 549 
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and sequencing depth. Considering these caveats, limitations and challenges during the 550 
experimental design process is imperative, as every potential variant called represents a 551 
hypothesis to be tested. Consequently, the identification of false positive or false negative 552 
variants can have significant consequences including the loss of time and resources (O'Rawe 553 
et al., 2013), and may also lead to the spread of misinformation which can potentially be more 554 
damaging in the long term. 555 
 556 
6. Variant detection in non-model organisms such as parasites 557 
A major inadequacy of available variant analysis tools is the lack of recommendations for 558 
adaptation to non-model organisms, including many clinically important protozoa such as 559 
Plasmodium species, Toxoplasma gondii, Leishmania species, and other trypanosomatids. This 560 
is problematic as the molecular biology of protozoan pathogens is drastically different to that 561 
of model organisms, which includes a limited number of Metazoa, bacteria, and fungi that have 562 
been extensively studied (e.g., Homo sapiens, Mus musculus, Drosophila melanogaster, 563 
Escherichia coli, and Saccharomyces cerevisiae). Nonetheless, it is helpful to use studies 564 
conducted on well-researched model organisms as a general guide for the study of non-model 565 
species, whilst retaining a certain degree of caution. In the human genome for example, SNPs 566 
occur on average once every 300 bases (~10 million SNPs), comprising approximately 0.1% 567 
of the entire genome (International HapMap Consortium, 2005; Jorde and Wooding, 2004; 568 
Reich et al., 2003). When comparing SNP frequencies across a diverse collection of taxa, 569 
expected rates are estimated at one SNP every 200–500 bases in non-coding DNA, and one 570 
SNP in every 500–1000 bases for coding DNA (Brumfield et al., 2003).  571 
The frequency of polymorphisms in P. falciparum is approximately 1 in every 400-800 572 
bases (Jeffares et al., 2007; Mu et al., 2007; Volkman et al., 2007), and 1 in 100 bases for T. 573 
gondii (Khan et al., 2006). Furthermore, the P. falciparum genome is extremely AT-rich, 574 
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consists of numerous repetitive sequences, and low complexity regions in protein sequences 575 
(Gardner et al., 2002; Pizzi and Frontali, 2001). As a result, sequencing and subsequent variant 576 
identification in protozoal genomes can be challenging, as these repetitive and low complexity 577 
sequences can hinder accurate read alignment and assembly (Battistuzzi et al., 2016; Talavera-578 
Lopez and Andersson, 2017). Ribeiro et al. (2015) explored potential sources of false positive 579 
variants, and deemed the quality of the reference used as having the largest effect on the rate 580 
of false positive calls. This is a cause for concern regarding the use of these variant calling 581 
algorithms for non-model organisms, as their genomes are sometimes highly fragmented or in 582 
the very early stages of analysis and annotation. These draft-quality genomes may have been 583 
misassembled, or may be the result of inadequate or incomplete sequencing, poor quality 584 
control, or insufficient validation.  585 
Protozoan parasites and the diseases they cause are a significant public health burden, 586 
causing in excess of a million deaths annually (Lozano et al., 2012). The highest contributors 587 
to this figure include malaria, leishmaniasis, and trypanosomiasis. The decreasing effectiveness 588 
of treatment options or vaccines, in concert with the increasing threat of drug resistance are 589 
applicable concerns for each of these diseases. As a result, SGS and TGS based genome-wide 590 
studies involving these organisms are becoming increasingly important, particularly those 591 
aiming to identify the genetic mechanisms of drug resistance and to monitor the expansion of 592 
resistance alleles in populations.  593 
 594 
6.1. Parasites, ploidy, and pooled samples 595 
Important considerations pertaining to clinically significant Protozoa and NGS sequencing and 596 
variant analysis, include ploidy, pooled samples, and mixed infections. While the majority of 597 
organisms such as plants, animals, and humans, are dominated by the diploid lifecycle stage, 598 
many eukaryotes, including Protozoa, alternate between different ploidy phases (Nuismer and 599 
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Otto, 2004). It has been reported that ploidy phases are a result of evolutionary selection, where 600 
diploidy is more likely to be favoured in a host species, compared to haploidy in a parasite 601 
species, based on host-parasite interactions. Challenges associated with detecting sequence 602 
variants in non-diploid parasite lifecycle stages however, include the ability to distinguish 603 
between sequencing errors and true variants that exist at a low frequency. This therefore has 604 
implications for the selection and implementation of both alignment and variant calling 605 
algorithms.  606 
 How accurately genomic variation can be identified and assigned to sub-genomes 607 
within a sample or individual, is dependent on experimental design, software selection and 608 
implementation, and the biological history or context of a species, including the lifecycle stage 609 
(Clevenger et al., 2015). Furthermore, while the presence of a unique set of haplotypes within 610 
an infection can be a direct measure of diversity, resolving these haplotypes is hindered by 611 
sequencing errors and de novo mutations in individual haplotypes (Trevino et al., 2017). While 612 
traditional Sanger sequencing is conducive to identifying major resistance alleles (i.e. those 613 
with >50% frequency), it is not sensitive enough to accurately detect minor alleles and mixed 614 
genotype infections (Talundzic et al., 2018). Advances in NGS and bioinformatics pipelines 615 
have addressed these shortcomings by offering a cost-effective, high-throughput alternative 616 
that requires a significantly reduced amount of template DNA, and the multiplexing of 617 
hundreds of samples and markers in one run. Consequently, many tools and protocols have 618 
been designed to handle such data generated from different organism lifecycle stages, and 619 
therefore ploidy levels, as well as those that accommodate pooled samples. 620 
Both FreeBayes (Garrison and Marth, 2012) and the GATK (McKenna et al., 2010) 621 
allow users to specify the ploidy of the organism under investigation, without restricting this 622 
option to diploid or haploid. FreeBayes uses a Bayesian framework to assist with detecting 623 
multi-allelic haplotypes, and can also operate as a frequency-based pooled variant caller, as 624 
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opposed to describing variants and haplotypes in terms of genotypes (Garrison and Marth, 625 
2012). Similarly, the GATK’s HaplotypeCaller is able to both deal with non-diploid organisms 626 
or lifecycle phases, whether they be haploid or polyploid, as well as pooled samples (McKenna 627 
et al., 2010). The user can either use the ‘-ploidy’ argument to specify the ploidy, or allow the 628 
tool to correctly predict the ploidy of a given sample at a given site. While the HaplotypeCaller 629 
can only process one ploidy phase at a time, the results from additional runs can later be 630 
combined, allowing multiple samples to be individually genotyped. The tool subsequently calls 631 
SNPs and indels via local reassembly of haplotypes.  632 
 Commonly in parasitology studies, samples may represent mixed infections or require 633 
pooling, where there is a need to not only detect rare or novel variants at low frequencies, but 634 
to also estimate allele frequencies from such pooled samples (Brockman et al., 2008). Allele 635 
frequencies can be accurately estimated through deep sequencing protocols of pooled 636 
populations, representing a rapid and economical method (Boitard et al., 2012). Pooling 637 
sequences from malaria infections however presents complications, including sample 638 
contamination with human DNA (Venkatesan et al., 2012), and the multiple potential origins 639 
of drug resistance mutations that can lead to soft sweeps, which in turn are difficult to detect 640 
(Nair et al., 2008; Nair et al., 2007). Cheeseman et al. (2015) for example described a two-tier 641 
approach for rare variant association testing of malaria parasites acquired directly from 642 
infections, by incorporating pooled Illumina sequencing and subsequent resequencing of 643 
limited parasite haplotypes. This method was able to accurately and robustly identify a known 644 
causal drug-resistance marker. 645 
Initially, many variant calling tools were limited to a specific sequencing platform, read 646 
alignment algorithm, and/or single sample variant analysis. However, tools such as VarScan 647 
(Koboldt et al., 2009) are designed to detect sequence variants from a number of short read 648 
alignment algorithms, with high specificity and sensitivity, and across both individual and 649 
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pooled samples. Variant calling with VarScan is compatible with sequencing data generated 650 
from both Roche/454 sequencing of single samples, as well as deep sequencing of pooled 651 
samples from Illumina platforms. Furthermore, VarScan’s documentation provides 652 
recommendations for input parameters and thresholds that are specific to each compatible 653 
alignment tool, which is especially appealing for users new to NGS analysis. Compensating 654 
for pooled data is a matter of selecting appropriate input parameters and thresholds such as 655 
read coverage and variant frequency, where you can for example specify a high read coverage 656 
threshold and a lower variant allele frequency to detect rare or novel variants. For variant 657 
calling across multiple samples, the ‘mpileup’ command from the SAMtools package is first 658 
run simultaneously for all input BAM files, where the output can be piped straight to VarScan 659 
for SNP and indel calling. Tools such as VarScan offer a powerful method for large-scale 660 
genetic variation studies for both individual and pooled samples, in concert with the high-661 
throughput and massively parallel sequencing technologies offered by current sequencing 662 
platforms.  663 
Malaria infections in endemic regions often exhibit multiple-genotype infections, 664 
consisting of mixtures of diverse parasite lineages (Anderson et al., 2000; Conway et al., 1991; 665 
Conway and McBride, 1991; Nkhoma et al., 2012). Such infections are thought to influence 666 
drug resistance (Hastings, 2006; Huijben et al., 2011), virulence evolution (Bell et al., 2006), 667 
and recombination rates (Conway et al., 1999), however they are poorly understood and 668 
challenging to address through traditional PCR genotyping and deep sequencing approaches. 669 
As a result, single-cell-sequencing (SCS) methods have been developed and exploited to 670 
elucidate the impact of such malaria infections, and isolate individual malaria haplotypes. 671 
Using a combination of cell sorting and WGA, Nair et al. (2014) produced high-quality 672 
material from red blood cells infected with P. falciparum and Plasmodium vivax, for 673 
sequencing on the Illumina HiSeq 2000 platform, and subsequent genotyping. Such an 674 
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approach is also valuable with respect to sampling, low parasitaemia, and culturing malaria 675 
parasites. While some malaria species such as P. falciparum are culturable long term, this is 676 
not feasible for other species such as P. vivax, where such alternative approaches can therefore 677 
be helpful (Noulin et al., 2013). The data revealed the presence of within-host variation and 678 
drug resistance haplotypes, where this SCS technique resulted in the accurate resolution of 679 
single-cell genotypes from complex infections, which can be used in the future to obtain 680 
parasite genome sequences directly from clinical blood samples.  681 
 682 
6.2. Population genetic studies of Toxoplasma gondii 683 
The global population genetic structure of T. gondii has been of major interest for decades, 684 
with studies on the topic confirming the existence of at least four major clonal lineages (Khan 685 
et al., 2011a). The within-lineage variation for three of the four major lineages occurring in the 686 
Northern Hemisphere is <0.01%, whereas the between lineage variation ranges from 687 
approximately 1-3% (Boyle et al., 2006). Based on genome-wide SNP comparisons of various 688 
clonal-lineage strains, the ancestor of T. gondii type II crossed with ancestral strains 689 
approximately 10,000 years ago to produce lineages I and III. Another study identified >106 690 
SNPs between ten T. gondii strains from Europe, North America, and South America, that 691 
could potentially reveal strain-specific phenotypes (Minot et al., 2012). This SNP data was 692 
used to identify shared haplotype blocks across the strains, and generate a haplotype map for 693 
the species. Based on extensive SNP identification across various populations of T. gondii, 694 
even a limited number of mating events can drastically modify the population structure of a 695 
sexually reproducing pathogen and facilitate the emergence of new clonal genotypes (Boyle et 696 
al., 2006). Characterisation of the almost non-existent polymorphisms within clonal lineages 697 
revealed a history of infrequent yet important sexual recombination events followed by strong 698 
selective sweeps, causing rapid clonal expansion within the species. 699 
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The cyst-forming apicomplexan parasite Neospora caninum causes hind limb paralysis 700 
in canines and abortion or stillbirth in cattle, and is closely related to T. gondii (Dubey et al., 701 
1988). Calarco et al. (2018) generated RNA-seq data using Illumina HiSeq2000 paired-end 702 
sequencing, for two N. caninum isolates with distinct differences in pathogenicity in murine 703 
models. The implementation of a variant analysis pipeline using the sequencing data produced 704 
enabled the identification of over 3000 SNPs differentiating the two isolates. Numerous non-705 
synonymous SNPs were present within protein-coding genes, and 19 SNP-dense regions were 706 
identified and found to be unevenly distributed along the N. caninum genome.  707 
 708 
6.3. Sequencing and population genetics of Trypanosomatids 709 
The leishmaniases includes several neglected tropical diseases caused by species of the genus 710 
Leishmania, where over 350 million people live at risk of these diseases globally (Alvar et al., 711 
2012). Leishmania sp. are endemic in 98 countries, with an estimated 0.7-1 million new cases, 712 
and 20,000-30,000 Leishamania-associated deaths reported per annum. In 2005, the genome 713 
of the first Leishmania species, L. major, was sequenced using classical shotgun Sanger 714 
sequencing technology (Ivens et al., 2005). The advancement of sequencing technologies in 715 
subsequent years however, saw draft genomes being generated for an increasing number of 716 
Leishmania species, most of which took advantage of popular Illumina NGS platforms, which 717 
boasted the highest throughput and lowest sequencing costs per base (Leprohon et al., 2015). 718 
However, using short-read sequencing approaches presented challenges when attempting to 719 
handle highly repetitive DNA sequences and tandemly arranged identical genes, which are 720 
characteristic of Leishmania genomes (Alonso et al., 2016; Batra et al., 2019; Requena, 2011; 721 
Ubeda et al., 2014). As a result, TGS technologies are now being exploited to improve and re-722 
sequence the draft genomes available for a number Leishmania species and strains.  723 
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For example, Gonzalez-de la Fuente et al. (2017) re-sequenced the L. infantum genome 724 
using a combined sequencing approach, taking advantage of long reads generated by PacBio 725 
sequencing, and short paired-end reads produced by Illumina technology. This study 726 
demonstrated the value of including PacBio reads when assembling a quality Leishmania 727 
genome, and the relevance of Illumina reads when joining contigs and extending chromosome 728 
ends. This de novo assembly was suggested to replace previous draft genomes, based on the 729 
resulting increased genome size, the identification of incorrectly assembled regions, and the 730 
numerous newly annotated or corrected genes presented. Similarly, Lypaczewski et al. (2018) 731 
published a complete reference genome assembly for L. donovani, after exploiting sequencing 732 
data from both SGS Illumina and TGS PacBio technologies. Previously, the L. donovani 733 
genome assembly contained 2,154 contigs, consisting of 7,969 protein coding genes, and an 734 
N50 value of 45,436, representing a measure of contiguity (Downing et al., 2011). The new 735 
assembly published by Lypaczewski et al. (2018) however, contained 36 contigs, 8,633 protein 736 
coding genes, and a 22-fold increase in N50. This study therefore improved on the quality of 737 
the previously published assembly by closing an estimated 2000 gaps across the 36 738 
chromosomes, presenting new and re-annotated protein-coding genes and non-coding RNA 739 
genes, and extending multiple chromosomes. This approach also resulted in the correct 740 
assembly of highly repetitive L. donovani virulence gene clusters, and the accurate 741 
identification of SNPs and indels between distinct strains of the species, highlighting how 742 
complete, high-quality reference genome assemblies are vital for functional genomic studies. 743 
It is through advances in -omics technologies that determinants of disease phenotype 744 
and drug efficacies are being investigated, to improve our knowledge of the pathogenesis of 745 
leishmaniasis and the drug resistance mechanisms employed. In 2011, a high-quality reference 746 
genome was generated using the combined SGS technologies of 454 Life Sciences and 747 
Illumina platforms for L. donovani, which is a major cause of the fatal visceral form of 748 
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leishmaniasis (VL) (Downing et al., 2011). This approach allowed errors within homopolymer 749 
stretches produced by pyrosequencing, to be corrected using reads from Illumina’s Genome 750 
Analyser, in addition to resolving gaps and read errors in the assembly. The resulting high-751 
quality genome was used to study intra-species genetic diversity across 16 Nepalese and Indian 752 
clinical isolates of L. donovani, possessing diverse drug susceptibility profiles. Read alignment 753 
to the new reference genome provided important information on mechanisms of drug resistance 754 
utilised by L. donovani, which were not apparent using traditional multilocus typing 755 
approaches. Furthermore, the SNP diversity of these isolates when compared with other 756 
Leishmania species, provided evidence that selection was acting on various surface- and 757 
transport-related genes in this population of L. donovani, including several genes associated 758 
with drug resistance. 759 
The causative agent of Chagas disease (American trypanosomiasis) is Trypanosoma 760 
cruzi, which affects over 8 million people per annum (Rassi et al., 2010). The first whole 761 
genome sequence for T. cruzi was published in 2005, which was based on shotgun Sanger 762 
sequencing technology (El-Sayed et al., 2005). While this draft genome was valuable at the 763 
time, it was highly fragmented with a total of 4,098 contigs, most of which were less than 150 764 
kb in length, and only 12 contigs exceeded 100 kb in size. Inherent complexities of 765 
trypanosomatid genomes such as Trypanosoma and Leishmania species, include repetitive 766 
sequences and tandemly arranged genes, which can now be tackled by exploiting the longer 767 
reads generated by TGS technologies, to generate genome assemblies of higher quality than 768 
their predecessors (Berna et al., 2018). As discussed in section 2.3, Berna et al. (2018) 769 
assembled and annotated the genomes of two T. cruzi clones using PacBio sequencing 770 
technology, improving on previous versions by resolving fragmented assemblies and repetitive 771 
sequences. The final genome assemblies contained 1142 and 599 contigs, with improved N50 772 
values of 265 and 318 kb. Using the assemblies obtained from PacBio SMRT sequencing 773 
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technology, novel repetitive sequences were revealed, and copy numbers of multi-gene 774 
families and tandemly arrayed genes could be accurately calculated.    775 
With respect to population genetics, a 2012 study used sequence data generated from 776 
strains of T. cruzi belonging to various lineages, to facilitate the generation of a map of the 777 
genetic diversity present within the species, and to highlight the polymorphic nature of the T. 778 
cruzi genome (Ackermann et al., 2012). The study took advantage of the plethora of sequencing 779 
data now available for the species to detect SNPs, including transcriptome data and genomes 780 
generated using 454 Life Sciences’ FLX Titanium platform. Focusing on protein coding 781 
genomic regions, 97% of high-quality SNPs present across 47 loci were validated, where a set 782 
of core, highly conserved genes were identified as being under purifying selection. There were 783 
also a number of mutations that introduced or removed a stop codon, and tri-allelic and tetra-784 
allelic SNPs that could be utilised in strain typing assays. 785 
 786 
6.4. The importance of SNP detection in malaria causing Plasmodium falciparum 787 
The annual WHO World Malaria Report reported approximately 216 million malaria cases in 788 
2017, and just under half a million deaths resulting from malaria. Consequently, malaria 789 
research efforts generally focus on the mechanisms of Plasmodium sp. drug resistance, 790 
potential vaccine targets, and vector control strategies. In 2002, the first draft genome for P. 791 
falciparum was sequenced using Sanger shotgun sequencing technology (Gardner et al., 2002). 792 
However, extensive efforts since then have been dedicated to resequencing Plasmodium 793 
genomes using NGS approaches, to assist in tackling challenges associated with sequencing 794 
the AT-rich genome of the malaria parasite, and to identify genes and loci associated with 795 
clinical outcomes and drug resistance (Le Roch et al., 2012). Illumina sequencing technology 796 
has been considered the most popular method for sequencing Plasmodium species, and a range 797 
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of techniques and combined approaches have been used to further improve and study these 798 
genomes (Bartfai et al., 2010; Kozarewa et al., 2009; Ponts et al., 2010). 799 
While first and second generation sequencing technologies provide accuracy, massive 800 
parallelisation, and high-throughput, their availability and use in developing countries, 801 
especially in field hospitals, is not always feasible (Runtuwene et al., 2018). However, the 802 
development of TGS platforms has become increasingly attractive for sequencing Plasmodium 803 
genomes, especially for laboratory strains. Such samples can be useful in-vitro models for 804 
investigating parasite pathogenesis, and for clinically important species lacking available 805 
genetic information (Benavente et al., 2018; Bryant et al., 2018; Rutledge et al., 2017). For 806 
example, Runtuwene et al. (2018) applied ONT’s portable MinION sequencing platform with 807 
PCR amplification, for genotyping laboratory adapted strains of P. falciparum and clinical 808 
samples containing the parasite. This study showed that the MinION device could generate 809 
long reads of acceptable quality, though at a sequencing accuracy of typically less than 90%. 810 
Since the average base-calling accuracy of the sequence was only 74.3%, it was suggested that 811 
a sequencing depth >50 greatly improved the accuracy of SNP calling. 812 
A 2014 study (Preston et al., 2014) investigated the genetic variation in the 813 
mitochondria and apicoplast of 711 P. falciparum isolates from 14 countries. The study 814 
established a geographically informative, highly specific 23-SNP barcode, based on a high 815 
degree of linkage, where the linkage disequilibrium analyses inferred the co-transmission of 816 
each organellar genome and the non-recombining nature of the SNPs identified. There was also 817 
a higher proportion (77.8%) of non-synonymous mutations in SNPs within coding regions of 818 
the apicoplast compared to 61.8% on the nuclear genome and only 31.3% on the mitochondrial 819 
genome. This suggests that the organellar genomes are subject to different selective pressures, 820 
such that the conserved mitochondrial genes appear to be under purifying selection, whereas 821 
the apicoplast genes may instead be experiencing diversifying selection. 822 
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The emergence of chloroquine-resistant P. falciparum parasites is at least partially 823 
attributable to mutations in the molecular markers pfmdr1and pfcrt (Moers et al., 2015; Reed 824 
et al., 2000). To address the increased morbidity and mortality associated with malaria, as a 825 
result of selection of pfmdr1and pfcrt resistance alleles (Ashley et al., 2014; Nag et al., 2017), 826 
in the mid-1990s artemisinin-based combination therapies (ACTs) were introduced, and 827 
subsequently recommended by the WHO in 2005 as first-line treatments for P. falciparum 828 
malaria infections. However, progress made towards controlling and eradicating malaria 829 
worldwide by the availability and use of ACTs, is constantly under threat due to the 830 
geographical spread of artemisinin resistance. Plasmodium falciparum has experienced 831 
selective pressure due to the widespread and long term administration of numerous 832 
antimalarials including the abandoned drugs chloroquine and quinine, which are now obsolete 833 
for treating malaria (Nag et al., 2017). To prevent the recurrence of widespread resistance to 834 
ACTs, recent efforts have focused on identifying the P. falciparum genes, and specifically, the 835 
mutations in these genes that are indicators of resistance to ACTs and other antimalarials.  836 
Mutations in the regions of the pfcrt gene encoding three transmembrane domains are 837 
responsible for chloroquine resistance (Cooper et al., 2007), while point mutations in both the 838 
pfdhfr and pfdhps genes are associated with resistance to sulfadoxine-pyrimethamine (Abdul-839 
Ghani et al., 2013). Ariey et al. (2014) demonstrated an association between mutations in the 840 
Kelch 13 gene propeller domain and artemisinin resistance using whole-genome paired-end 841 
sequencing of clinical isolates from Cambodia, performed on an Illumina HiSeq platform. This 842 
study classified the polymorphic K13-propeller domain as a useful molecular marker for 843 
monitoring the emergence and expansion of artemisinin resistant P. falciparum across South 844 
East Asia. Numerous synonymous and non-synonymous mutations in the K13-propeller region 845 
related to the slow clearance of the parasites during treatment have now been identified (Ariey 846 
et al., 2014; Ashley et al., 2014; Takala-Harrison et al., 2015). 847 
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Key to monitoring the nature, development, and expansion of antimalarial drug 848 
resistance, is an understanding of the parasite’s susceptibility to available drugs and the 849 
geographical origin and spread of resistance alleles. It is clear that the high-throughput 850 
capabilities, resolution, and scalability that SGS and TGS technologies offer, are conducive to 851 
developing tools that improve our knowledge on the mechanisms of drug resistance in malaria-852 
causing parasites. 853 
 854 
7. Identifying large structural variants using NGS data 855 
In addition to the detection of polymorphisms located within functionally significant genes, 856 
larger variations such as SVs and copy number variation (CNVs) are routinely explored using 857 
SGS and TGS data (Figure 3). As expected, these large sequence variants affect phenotypic 858 
diversity within and between populations, and are implicated in a range of human diseases 859 
(Tattini et al., 2015). Structural variants are estimated to represent 1.2% of sequence variation 860 
in human genomes, compared to the existence of SNPs occupying only 0.1% of the genome 861 
(Pang et al., 2010). In protozoa, large SVs such as deletions and CNVs have been linked to 862 
clinically significant phenotypes, including drug resistance (Cowman et al., 1994; Downing et 863 
al., 2011; Papadopoulou et al., 1998), virulence (Khan et al., 2009), and changes in gene 864 
expression (Gonzales et al., 2008; Mackinnon et al., 2009). There are several in-silico tools 865 
available for detecting SVs using SGS and TGS data, each with their own unique inputs and 866 
output formats, underlying models, advantages and limitations. It has been suggested however, 867 
that it is not possible to identify the complete spectrum of SVs within genomes using a single 868 
tool, where a consensus approach is recommended (Lam et al., 2012; Mimori et al., 2013; 869 
Wong et al., 2010).  870 
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 871 
Figure 3. Visual summary of the types of sequence variants and large structural variants. 
The sequence variants panel displays both single base changes (SNPs) and single insertions or deletions of bases (indels) spanning small nucleotide 
regions. These changes can either result in non-synonymous or synonymous mutations depending on whether an amino acid change or frame shift 
occurs in the corresponding protein coding sequence. The letters in the structural variants panel represent large spanning genomic segments or 
genes
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In T. gondii differences in virulence observed between lineages I and III were attributed 872 
to expression differences in ROP18 (Khan et al., 2009), a serine/threonine kinase secreted by 873 
rhoptries that phosphorylates host cell proteins (Taylor et al., 2006). This differential 874 
expression was traced to a large upstream DNA segment in the regulatory element of ROP18 875 
present only within the avirulent type III strain, which alters transcription of the gene. As this 876 
upstream region was also found to exist in the closely related parasite N. caninum, it was 877 
proposed that this segment of DNA was present in a common ancestor of all surviving T. gondii 878 
strains, though lost through a large DNA rearrangement in the more recently derived ancestor 879 
of the virulent lineages I and II. Additionally, strong evidence for positive selection was 880 
observed for ROP18, which possesses three atypically divergent alleles making it unusually 881 
polymorphic. 882 
Previously, the detection of CNVs has exploited quantitative PCR (qPCR) 883 
methodologies, which are also imperfect (Beghain et al., 2016). However, the advancement of 884 
whole-genome sequencing technologies has facilitated more extensive analyses of such 885 
genomic variations, which subsequently requires the development of detection tools to respond 886 
to the availability of such data. Beghain et al. (2016) addressed the ability to detect CNVs from 887 
Cambodian P. falciparum isolates, using classical qPCR, compared to short paired-end reads 888 
from whole-genome sequencing, generated on the Illumina HiSeq platform. The algorithm 889 
PlasmoCNVScan was developed to better handle the unique nature of Plasmodium CNVs, 890 
which are not accommodated for by other available methods. Comparable results were 891 
observed between the two approaches taken in the study, demonstrating how such tools and 892 
sequencing technologies are conducive to studying the mechanisms of variations such as 893 
CNVs, to better understanding adapting parasite genomes.  894 
Through the identification of SNPs and SVs using whole-genome sequencing of 895 
clinical L. donovani isolates generated from both Life Sciences and Illumina platforms, 896 
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Downing et al. (2011) detected genes with variable patterns of diversity in drug resistant 897 
samples, specifically associated with CNVs. Tests for selective pressures regarding the 898 
presence of SVs and SNPs, identified a set of protein-coding genes subject to adaptive 899 
evolution in this L. donovani population. While there was minimal SNP variation present, 900 
which is typically reflective of a homogenous genetic background, there were extensive SVs 901 
thought to be responsible for locus-specific changes in gene copy number, including whole 902 
chromosome CNVs and the generation of extrachromosomal fragments. Within the 17 strains 903 
studied, a pattern of ancient adaptive evolution was observable for six genes related to 904 
translation and RNA stability. This study also provided evidence of positive selection operating 905 
at loci encoding ribosomal components and RNA-binding proteins. This included SVs at two 906 
loci essential for translation, and thought to responsible for differences in gene expression 907 
between antimonial resistant and antimonial sensitive parasite lines. 908 
 909 
8. Concluding Remarks 910 
There is an increasing demand for robust tools that exploit SGS and TGS data. This includes 911 
tools that perform variant analysis, facilitating the identification of functionally significant 912 
sequence polymorphisms within and between populations. These polymorphisms include 913 
SNPs, indels, large SVs, and CNVs for which there are a plethora of in-silico tools available 914 
that are lacking in standardization, often varying drastically in their performance and outputs. 915 
While selecting the most appropriate SGS/TGS workflow and software settings for answering 916 
a specific research question may seem trivial, these decisions will often be crucial for accurate 917 
variant calling and any associated downstream investigations. Several additional challenges 918 
exist with respect to many protozoan pathogens of clinical significance, including the absence 919 
of high-quality reference genomes for many species, and the fact that much of the software 920 
developed to answer pertinent questions, has not been optimised on non-model organisms that 921 
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often possess drastically different molecular characteristics. Other considerations when 922 
generating and analysing sequencing data for pathogenic Protozoa include the unique, complex 923 
nature of their genomes, the presence of mixed infections, preparing and pooling samples, and 924 
ploidy phases. However, as the field continues to develop it is expected these challenges will 925 
be overcome, particularly as SGS and TGS technologies are becoming increasingly available, 926 
making it simpler to generate high-quality reference genomes. Until such a time as tools 927 
optimised for protozoan pathogens become available, parasitologists embarking on SGS and 928 
TGS related projects are encouraged to consider their choice of sequencing technology and 929 
analysis tools carefully. To this end, we hope this review assists others in preventing 930 
unnecessary downstream expenses by avoiding the generation of erroneous data, and the use 931 
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